ID   287954-098-R-J1-PDC
AC   CVCL_F4D9
DR   NCI-PDMR; 3552
CC   Part of: NCI Patient-Derived Model Repository.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Characteristics: tumorigenic in NOD/SCID/IL2RgammaNULL (NSG) mice.
CC   Doubling time: 17 hours (NCI-PDMR=3552).
CC   HLA typing: A*02:01,03:01; B*39:01,40:01; C*03:04,12:03 (NCI-PDMR=3552).
CC   Microsatellite instability: Stable (MSS) (NCI-PDMR=3552).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.N2066Tfs*36 (c.6196_6197insCCACTCGCCA); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.373 (NCI-PDMR=3552).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.R156P (c.467G>C); Zygosity=Homozygous; Note=Likely Oncogenic, variant allele frequency: 1 (NCI-PDMR=3552).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.N778Tfs*40 (c.2332_2333insC); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.2541 (NCI-PDMR=3552).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.N778Kfs*41 (c.2333_2334insAAAC); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.2527 (NCI-PDMR=3552).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): NCI-PDMR=3552
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,19
ST   D19S433: 14
ST   D21S11: 29,30.2
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C4817; Ewing Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//